Efficacy and safety of anti‐obesity drugs in children and adolescents: systematic review and meta‐analysis
- 14 July 2010
- journal article
- research article
- Published by Wiley in Obesity Reviews
- Vol. 11 (8) , 593-602
Abstract
We undertook a meta‐analysis of randomized controlled trials to summarize the efficacy of anti‐obesity drugs in reducing BMI and improving health in children and adolescents. Data sources included Medline, Embase, the Cochrane controlled trials register and other registers of controlled trials, together with reference lists of identified articles. All data sources were searched from January 1996 to July 2008. We searched for double blind randomized placebo controlled trials of approved anti‐obesity drugs used in children and adolescents (age n = 573) met inclusion criteria. No trials of rimonabant were identified. Compared with placebo, sibutramine together with behavioural support reduced BMI by 2.20 kg/m2 (95% CI: 1.57 to 2.83) and orlistat together with behavioural support reduced BMI by 0.83 kg/m2 (95% CI 0.47 to 1.19). Sibutramine improved waist circumference, triglycerides and high density lipoprotein (HDL)‐cholesterol, but raised systolic and diastolic blood pressure and pulse. Orlistat increased rates of gastrointestinal side‐effects. We conclude that sibutramine in adolescents produces clinically meaningful reductions in BMI and waist circumference of approximately 0.63 SD, with improvements in cardiometabolic risk. Orlistat modestly reduces BMI (effect size approximately 0.24 SD) with a high prevalence of gastrointestinal adverse effects.Keywords
This publication has 27 references indexed in Scilit:
- Childhood Body-Mass Index and the Risk of Coronary Heart Disease in AdulthoodNew England Journal of Medicine, 2007
- Long term pharmacotherapy for obesity and overweight: updated meta-analysisBMJ, 2007
- Pharmacotherapy of Childhood ObesityDiabetes Care, 2007
- Use of sibutramine in obese mexican adolescents: A 6-month, randomized, double-blind, placebo-controlled, parallel-group trialClinical Therapeutics, 2006
- What is the best measure of adiposity change in growing children: BMI, BMI %, BMI z-score or BMI centile?European Journal of Clinical Nutrition, 2005
- Addition of orlistat to conventional treatment in adolescents with severe obesityEuropean Journal of Pediatrics, 2004
- Health consequences of obesityArchives of Disease in Childhood, 2003
- Central overweight and obesity in British youth aged 11–16 years: cross sectional surveys of waist circumferenceBMJ, 2003
- Body mass index reference curves for the UK, 1990.Archives of Disease in Childhood, 1995
- Systematic Reviews: Identifying relevant studies for systematic reviewsBMJ, 1994